Gilbert Greub
Overview
Explore the profile of Gilbert Greub including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
402
Citations
7179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lopes D, Grandbastien B, Orasch C, Greub G, Croxatto A, ProdHom G, et al.
Eur J Clin Microbiol Infect Dis
. 2025 Mar;
PMID: 40056306
Purpose: Regarding bloodstream infections (BSI) Enterococcus spp. rank among the top five most common organisms. Due to enterococci intrinsic resistance, empiric antibiotic therapy is often inappropriate and early identification becomes...
2.
Nordmann P, Helsens N, Kieffer N, Tinguely C, Greub G, Poirel L
Microbiol Spectr
. 2025 Mar;
:e0078224.
PMID: 40047444
Importance: This work reports on a totally novel diagnostic technique, the Rapid Amp NP test for the identification of amoxicillin/ampicillin resistance in bacteria that are sources of non-complicated urinary tract...
3.
Boattini M, Bianco G, Bastos P, Mavromanolaki V, Maraki S, Spiliopoulou A, et al.
Int J Antimicrob Agents
. 2025 Mar;
:107478.
PMID: 40024606
Introduction: Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe. Methods: We conducted a multicentre...
4.
Vocat A, Luraschi-Eggemann A, Antoni C, Cathomen G, Cichocka D, Greub G, et al.
Antimicrob Agents Chemother
. 2024 Nov;
69(1):e0131824.
PMID: 39601550
Novel drugs and improved diagnostics for (MTB) are urgently needed and go hand in hand. We evaluated the activity of two benzothiazinone drug candidates (MCZ, PBTZ169; BTZ043) and their main...
5.
Aubry C, Kebbi-Beghdadi C, Luraschi-Eggemann A, Cathomen G, Cichocka D, Sturm A, et al.
J Med Microbiol
. 2024 Nov;
73(11).
PMID: 39513692
Antibiotic tolerance corresponds to the bacterial ability to survive a transient exposure to antibiotics and is often associated with treatment failure. Current methods of identifying tolerance based on bacterial growth...
6.
Desai A, Otter A, Koopmans M, Granata G, Grobusch M, Tunali V, et al.
IJID Reg
. 2024 Nov;
13:100456.
PMID: 39507390
No abstract available.
7.
Desai A, Otter A, Koopmans M, Granata G, Grobusch M, Tunali V, et al.
Int J Infect Dis
. 2024 Oct;
149:107251.
PMID: 39453835
No abstract available.
8.
Tagini F, Belkoniene M, Jaton K, Opota O, Greub G
J Med Microbiol
. 2024 Sep;
73(9).
PMID: 39320350
is responsible for the classical Whipple's disease. Recently, a new species was described in a Belgian immunocompromised patient with pleuritis. There is currently no specific molecular diagnostic test detecting other...
9.
Germuskova Z, Sosa E, Campillay Lagos A, Aamot H, Beale M, Bertelli C, et al.
Microbes Infect
. 2024 Sep;
26(8):105410.
PMID: 39218348
No abstract available.
10.
Carrara A, Bertelli C, Gardiol C, Marquis B, Andrey D, Schrenzel J, et al.
Sci Rep
. 2024 Aug;
14(1):19804.
PMID: 39191804
Fusobacterium necrophorum is a Gram-negative anaerobic bacterium responsible for localized infections of the oropharynx that can evolve into bacteremia and/or septic thrombophlebitis of the jugular vein or peritonsillar vein, called...